Zhou Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhou Zhou has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Xiao Han Hu
Department of Dermatology, Chinese People’s Liberation Army Western Theater Command General Hospital, Chengdu, China
5 shared publicationsDan Dan Zhan
Department of Dermatology, Chinese People’s Liberation Army Western Theater Command General Hospital, Chengdu, China
3 shared publicationsMin Li
Department of Dermatology, Chinese People’s Liberation Army Western Theater Command General Hospital, Chengdu, China
3 shared publicationsYu Wang
Department of Dermatology, Chinese People’s Liberation Army Western Theater Command General Hospital, Chengdu, China
3 shared publications- Min Li
Department of Dermatology, The General Hospital of Western Theater Command, Chengdu, China
2 shared publications Ming Zhang
Department of Dermatology Chinese People's Liberation Army Western Theater Command General Hospital Chengdu China
2 shared publications
Latest Publications
- Open Access
- 31 December 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16763
Unraveling the Causal Relationship Between Blood Metabolites and Acne: A Metabolomic Mendelian Randomization Study
Background: Acne is a common skin disorder that may be linked to metabolic dysfunction. However, the causal impact of blood metabolites on acne has not been thoroughly investigated. Methods: We performed a metabolome‐wide Mendelian randomization (MR) analysis on 486 blood metabolites and acne using a genome‐wide association dataset. The study included preliminary inverse‐variance weighted (IVW) analysis, multivariable MR analysis, linkage disequilibrium score (LDSC) analysis, and colocalization analysis, along with reverse MR to address potential reverse causation. Results: Our analysis identified 12 metabolites significantly associated with acne. LDSC analysis revealed a genetic correlation between nonanoylcarnitine and acne. Colocalization analysis confirmed shared genetic variants, and metabolic pathway analysis implicated the arginine biosynthesis pathway and the selenocompound metabolism pathway in the development of acne. Conclusion: This study offers a comprehensive understanding of the causal relationships between plasma metabolites and acne. The findings provide insights into potential biomarkers and therapeutic targets for acne treatment, underscoring the need for further research.
- 31 December 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (1) , e16763
Open AccessUnraveling the Causal Relationship Between Blood Metabolites and Acne: A Metabolomic Mendelian Randomization Study
Background: Acne is a common skin disorder that may be linked to metabolic dysfunction. However, the causal impact of blood metabolites on acne has not been thoroughly investigated. Methods: We performed a metabolome‐wide Mendelian randomization (MR) analysis on 486 blood metabolites and acne using a genome‐wide association dataset. The study included preliminary inverse‐variance weighted (IVW) analysis, multivariable MR analysis, linkage disequilibrium score (LDSC) analysis, and colocalization analysis, along with reverse MR to address potential reverse causation. Results: Our analysis identified 12 metabolites significantly associated with acne. LDSC analysis revealed a genetic correlation between nonanoylcarnitine and acne. Colocalization analysis confirmed shared genetic variants, and metabolic pathway analysis implicated the arginine biosynthesis pathway and the selenocompound metabolism pathway in the development of acne. Conclusion: This study offers a comprehensive understanding of the causal relationships between plasma metabolites and acne. The findings provide insights into potential biomarkers and therapeutic targets for acne treatment, underscoring the need for further research.
- 27 September 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (19) , 17103-17113
Predicting cutaneous malignant melanoma patients’ survival using deep learning: a retrospective cohort study
Background Cutaneous malignant melanoma (CMM) has the worst prognosis among skin cancers, especially metastatic CMM. Predicting its prognosis accurately could direct clinical decisions. Methods The Surveillance, Epidemiology, and End Results database was screened to collect CMM patients’ data. According to diagnosed time, patients were subdivided into three cohorts, train cohort (diagnosed between 2010 and 2013), validation cohort (diagnosed in 2014), and test cohort (diagnosed in 2015). Train cohort was used to train deep learning survival model for cutaneous malignant melanoma (DeepCMM). DeepCMM was then evaluated in train cohort and validation cohort internally, and validated in test cohort externally. Results DeepCMM showed 0.8270 (95% CI, confidence interval, CI 0.8260–0.8280) as area under the receiver operating characteristic curve (AUC) in train cohort, 0.8274 (95% CI 0.8286–0.8298) AUC in validation cohort, and 0.8303 (95% CI 0.8289–0.8316) AUC in test cohort. Then DeepCMM was packaged into a Windows 64-bit software for doctors to use. Conclusion Deep learning survival model for cutaneous malignant melanoma (DeepCMM) can offer a reliable prediction on cutaneous malignant melanoma patients’ overall survival. Graphical abstract
- 27 September 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (19) , 17103-17113
Predicting cutaneous malignant melanoma patients’ survival using deep learning: a retrospective cohort study
Background Cutaneous malignant melanoma (CMM) has the worst prognosis among skin cancers, especially metastatic CMM. Predicting its prognosis accurately could direct clinical decisions. Methods The Surveillance, Epidemiology, and End Results database was screened to collect CMM patients’ data. According to diagnosed time, patients were subdivided into three cohorts, train cohort (diagnosed between 2010 and 2013), validation cohort (diagnosed in 2014), and test cohort (diagnosed in 2015). Train cohort was used to train deep learning survival model for cutaneous malignant melanoma (DeepCMM). DeepCMM was then evaluated in train cohort and validation cohort internally, and validated in test cohort externally. Results DeepCMM showed 0.8270 (95% CI, confidence interval, CI 0.8260–0.8280) as area under the receiver operating characteristic curve (AUC) in train cohort, 0.8274 (95% CI 0.8286–0.8298) AUC in validation cohort, and 0.8303 (95% CI 0.8289–0.8316) AUC in test cohort. Then DeepCMM was packaged into a Windows 64-bit software for doctors to use. Conclusion Deep learning survival model for cutaneous malignant melanoma (DeepCMM) can offer a reliable prediction on cutaneous malignant melanoma patients’ overall survival. Graphical abstract
- Open Access
- 20 September 2023
- Published by Springer Nature in Research Square
Unraveling the Causal Relationship between Blood Metabolites and Acne: A Metabolomic Mendelian Randomization Study
Background: Acne is a prevalent skin disorder with potential links to metabolic dysfunction. The causal impact of blood metabolites on acne remains underexplored. Methods: Using a genome-wide association dataset, we conducted a metabolome-wide Mendelian randomization (MR) analysis on 486 blood metabolites and acne. The study included preliminary IVW analysis, multivariable MR analysis, linkage disequilibrium score (LDSC)analysis, and colocalization analysis, with reverse MR to address reverse causation. Results: We identified 12 metabolites with significant associations with acne. LDSC analysis revealed a genetic correlation between nonanoylcarnitine and acne. Colocalization analysis confirmed shared genetic variants, and metabolic pathway analysis implicated the Arginine biosynthesis pathway and the Selenocompound metabolism pathway in acne development. Conclusion:Our study provides a comprehensive understanding of the causal relationships between plasma metabolites and acne. The findings offer insights into potential biomarkers and therapeutic targets for acne treatment and emphasize the need for further research.
- 20 September 2023
- Published by Springer Nature in Research Square
Open AccessUnraveling the Causal Relationship between Blood Metabolites and Acne: A Metabolomic Mendelian Randomization Study
Background: Acne is a prevalent skin disorder with potential links to metabolic dysfunction. The causal impact of blood metabolites on acne remains underexplored. Methods: Using a genome-wide association dataset, we conducted a metabolome-wide Mendelian randomization (MR) analysis on 486 blood metabolites and acne. The study included preliminary IVW analysis, multivariable MR analysis, linkage disequilibrium score (LDSC)analysis, and colocalization analysis, with reverse MR to address reverse causation. Results: We identified 12 metabolites with significant associations with acne. LDSC analysis revealed a genetic correlation between nonanoylcarnitine and acne. Colocalization analysis confirmed shared genetic variants, and metabolic pathway analysis implicated the Arginine biosynthesis pathway and the Selenocompound metabolism pathway in acne development. Conclusion:Our study provides a comprehensive understanding of the causal relationships between plasma metabolites and acne. The findings offer insights into potential biomarkers and therapeutic targets for acne treatment and emphasize the need for further research.
- Open Access
- 9 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Detecting potential causal relationship between inflammatory bowel disease and rosacea using bi-directional Mendelian randomization
The association between rosacea and inflammatory bowel disease (IBD) has been studied in previous observational studies. It is unclear, however, whether the association is causal or not. Independent genetic variants for IBD were chosen as instruments from published Genome-wide association studies (GWAS) studies involving 38,155 cases with an IBD diagnosis and 48,485 controls in order to investigate the causal effect of IBD on rosacea. Summarized data for rosacea were gathered from various GWAS studies that included 1195 cases and 211,139 controls without rosacea. Reverse-direction Mendelian randomization (MR) analysis was done to investigate the relationship between genetically proxied rosacea and IBD. With the use of the inverse variance-weighted (IVW), MR-Egger, and weighted median approaches, a 2-sample Mendelian randomization study was carried out. Analysis of heterogeneity and sensitivity was performed to examine the pleiotropy and robustness of effect estimates. The forward-direction of the MR study was to reveal that genetic predisposition to IBD including its two main subtypes: Crohn’s disease (CD) and ulcerative colitis (UC) was associated with an increased risk of rosacea. The reverse-direction MR analyses did not demonstrate that a genetic predisposition to rosacea was associated with total IBD, UC and CD. Our findings provided evidence for a causal impact of IBD, UC, and CD on rosacea, but not vice versa. The elevated incidence of rosacea in patients with IBD should be recognized by doctors to make an early diagnosis and initiate specialized therapy.
- 9 September 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-9
Open AccessDetecting potential causal relationship between inflammatory bowel disease and rosacea using bi-directional Mendelian randomization
The association between rosacea and inflammatory bowel disease (IBD) has been studied in previous observational studies. It is unclear, however, whether the association is causal or not. Independent genetic variants for IBD were chosen as instruments from published Genome-wide association studies (GWAS) studies involving 38,155 cases with an IBD diagnosis and 48,485 controls in order to investigate the causal effect of IBD on rosacea. Summarized data for rosacea were gathered from various GWAS studies that included 1195 cases and 211,139 controls without rosacea. Reverse-direction Mendelian randomization (MR) analysis was done to investigate the relationship between genetically proxied rosacea and IBD. With the use of the inverse variance-weighted (IVW), MR-Egger, and weighted median approaches, a 2-sample Mendelian randomization study was carried out. Analysis of heterogeneity and sensitivity was performed to examine the pleiotropy and robustness of effect estimates. The forward-direction of the MR study was to reveal that genetic predisposition to IBD including its two main subtypes: Crohn’s disease (CD) and ulcerative colitis (UC) was associated with an increased risk of rosacea. The reverse-direction MR analyses did not demonstrate that a genetic predisposition to rosacea was associated with total IBD, UC and CD. Our findings provided evidence for a causal impact of IBD, UC, and CD on rosacea, but not vice versa. The elevated incidence of rosacea in patients with IBD should be recognized by doctors to make an early diagnosis and initiate specialized therapy.
- Open Access
- 11 November 2022
- Published by Springer Nature in Research Square
Inflammatory bowel disease and rosacea: causal association analysis using bi-directional Mendelian randomization
Background: The association between rosacea and inflammatory bowel disease (IBD) has been studied in previous observational studies. It is unclear, however, whether the association is causal or not. Methods: Independent genetic variants for IBD were chosen as instruments from published GWAS studies involving 38155 cases with an IBD diagnosis and 48485 controls in order to investigate the causal effect of IBD on rosacea. Summarized data for rosacea were gathered from various GWAS studies that included 1195 cases and 211139 controls without rosacea. Reverse-direction MR analysis was done to investigate the relationship between genetically proxied rosacea and IBD. With the use of the inverse variance-weighted (IVW), MR-Egger, and weighted median approaches, a 2-sample Mendelian randomization study was carried out. Analysis of heterogeneity and sensitivity was performed to examine the pleiotropy and robustness of effect estimates. Results: The forward-direction of the MR study was to reveal that genetic predisposition to IBD (OR: 1.1291; 95% CI: 1.0444 to 1.2206), UC (OR: 1.2030; 95% CI: 1.0867 to 1.3318) and CD (OR: 1.1291; 95% CI: 1.0444 to 1.2206; p=0.0023) was associated with an increased risk of rosacea. The reverse-direction MR analyses did not demonstrate that a genetic predisposition to rosacea was not associated with total IBD (OR: 0.9683; 95% CI: 0.9112 to 1.0291), UC (OR: 0.9714; 95% CI: 0.8949 to 1.0545) and CD (WM: OR: 0.9751; 95% CI: 0.8971 to 1.0598; p=0.5525). Conclusion: Our findings provided evidence for a causal impact of IBD, UC, and CD on rosacea, but not vice versa. The elevated incidence of rosacea in patients with IBD should be recognized by doctors to make an early diagnosis and initiate specialized therapy.
- 11 November 2022
- Published by Springer Nature in Research Square
Open AccessInflammatory bowel disease and rosacea: causal association analysis using bi-directional Mendelian randomization
Background: The association between rosacea and inflammatory bowel disease (IBD) has been studied in previous observational studies. It is unclear, however, whether the association is causal or not. Methods: Independent genetic variants for IBD were chosen as instruments from published GWAS studies involving 38155 cases with an IBD diagnosis and 48485 controls in order to investigate the causal effect of IBD on rosacea. Summarized data for rosacea were gathered from various GWAS studies that included 1195 cases and 211139 controls without rosacea. Reverse-direction MR analysis was done to investigate the relationship between genetically proxied rosacea and IBD. With the use of the inverse variance-weighted (IVW), MR-Egger, and weighted median approaches, a 2-sample Mendelian randomization study was carried out. Analysis of heterogeneity and sensitivity was performed to examine the pleiotropy and robustness of effect estimates. Results: The forward-direction of the MR study was to reveal that genetic predisposition to IBD (OR: 1.1291; 95% CI: 1.0444 to 1.2206), UC (OR: 1.2030; 95% CI: 1.0867 to 1.3318) and CD (OR: 1.1291; 95% CI: 1.0444 to 1.2206; p=0.0023) was associated with an increased risk of rosacea. The reverse-direction MR analyses did not demonstrate that a genetic predisposition to rosacea was not associated with total IBD (OR: 0.9683; 95% CI: 0.9112 to 1.0291), UC (OR: 0.9714; 95% CI: 0.8949 to 1.0545) and CD (WM: OR: 0.9751; 95% CI: 0.8971 to 1.0598; p=0.5525). Conclusion: Our findings provided evidence for a causal impact of IBD, UC, and CD on rosacea, but not vice versa. The elevated incidence of rosacea in patients with IBD should be recognized by doctors to make an early diagnosis and initiate specialized therapy.